Castle Biosciences Inc. (CSTL) Reports In-Line Q1 EPS

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q1 EPS of ($0.49), in-line with the analyst estimate of ($0.49). Revenue for the quarter came in at $83.7 million versus the consensus estimate of $77.46 million.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'
• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold